Cargando…
Oncologists’ Perceptions of Drug Affordability Using NCCN Evidence Blocks: Results from a National Survey
BACKGROUND: The increasing prevalence of cancer coupled with approvals of new drugs and technologies used in therapy have brought increased scrutiny to the cost and value of treatments in oncology. To address the rising concern about oncology drug costs, several organizations have developed value fr...
Autores principales: | Shah-Manek, Bijal, Wong, William, Ravelo, Arliene, DiBonaventura, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398167/ https://www.ncbi.nlm.nih.gov/pubmed/29451078 http://dx.doi.org/10.18553/jmcp.2018.17449 |
Ejemplares similares
-
Real-world usage and clinical outcomes of alectinib among post-crizotinib progression anaplastic lymphoma kinase positive non-small-cell lung cancer patients in the USA
por: DiBonaventura, Marco D, et al.
Publicado: (2017) -
Adherence to recommended clinical guidelines in extensive disease small-cell lung cancer across the US, Europe, and Japan
por: DiBonaventura, Marco D, et al.
Publicado: (2019) -
Oncologists’ Attitudes Toward Cancer Care Affordability
por: Aviki, Emeline M., et al.
Publicado: (2022) -
Levels of Evidence for Radiation Therapy Recommendations in the National Comprehensive Cancer Network (NCCN) Clinical Guidelines
por: Noy, Miguel Angel, et al.
Publicado: (2021) -
Patient Perspective on the Burden of Skin and Joint Symptoms of Psoriatic Arthritis: Results of a Multi-National Patient Survey
por: Merola, Joseph F., et al.
Publicado: (2019)